Literature DB >> 16904291

No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population.

Mamoru Tochigi1, Motomu Suga, Jun Ohashi, Takeshi Otowa, Hidenori Yamasue, Kiyoto Kasai, Tadafumi Kato, Yuji Okazaki, Nobumasa Kato, Tsukasa Sasaki.   

Abstract

Several lines of evidence have suggested that the metabotropic glutamate receptor 3 (GRM3) gene is a candidate susceptibility gene for schizophrenia. To our knowledge, six studies have investigated the genetic association between GRM3 and schizophrenia, although the results have been quite controversial. In the present study, we investigated the association between the GRM3 gene and schizophrenia in 402 Japanese people by analyzing 10 single nucleotide polymorphisms (SNPs), including all SNPs that showed significant results in previous studies. We observed no significant difference in allelic frequencies or genotypic distributions of the 10 SNPs between the controls and patients. A permutation test showed no significant global differences in estimated haplotype frequencies between the controls and patients. Thus, the present study provides no positive evidence of an association between the GRM3 gene and schizophrenia in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904291     DOI: 10.1016/j.schres.2006.07.008

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

1.  Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia.

Authors:  Jeffrey R Bishop; Del D Miller; Vicki L Ellingrod; Timothy Holman
Journal:  Hum Psychopharmacol       Date:  2011-01       Impact factor: 1.672

Review 2.  Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.

Authors:  John H Krystal; Sanjay J Mathew; D Cyril D'Souza; Amir Garakani; Handan Gunduz-Bruce; Dennis S Charney
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

3.  A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations.

Authors:  Penelope A Lind; Stuart Macgregor; Jacqueline M Vink; Michele L Pergadia; Narelle K Hansell; Marleen H M de Moor; August B Smit; Jouke-Jan Hottenga; Melinda M Richter; Andrew C Heath; Nicholas G Martin; Gonneke Willemsen; Eco J C de Geus; Nicole Vogelzangs; Brenda W Penninx; John B Whitfield; Grant W Montgomery; Dorret I Boomsma; Pamela A F Madden
Journal:  Twin Res Hum Genet       Date:  2010-02       Impact factor: 1.587

Review 4.  Group II metabotropic glutamate receptors and schizophrenia.

Authors:  José L Moreno; Stuart C Sealfon; Javier González-Maeso
Journal:  Cell Mol Life Sci       Date:  2009-08-26       Impact factor: 9.261

Review 5.  Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.

Authors:  L Watis; S H Chen; H C Chua; S A Chong; K Sim
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

6.  Effects of metabotropic glutamate receptor 3 genotype on phonetic mismatch negativity.

Authors:  Yuki Kawakubo; Motomu Suga; Mamoru Tochigi; Masato Yumoto; Kenji Itoh; Tsukasa Sasaki; Yukiko Kano; Kiyoto Kasai
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

7.  Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis.

Authors:  Xiaoqin Yang; Guiping Wang; Yaodong Wang; Xia Yue
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-25       Impact factor: 2.570

Review 8.  Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs.

Authors:  Carolina Muguruza; J Javier Meana; Luis F Callado
Journal:  Front Pharmacol       Date:  2016-05-20       Impact factor: 5.810

9.  Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk.

Authors:  S M Saini; S G Mancuso; Md S Mostaid; C Liu; C Pantelis; I P Everall; C A Bousman
Journal:  Transl Psychiatry       Date:  2017-08-08       Impact factor: 6.222

10.  Metabotropic glutamate receptor 3 is associated with heroin dependence but not depression or schizophrenia in a Chinese population.

Authors:  Wei Jia; Rui Zhang; Bin Wu; Zun-xiao Dai; Yong-sheng Zhu; Ping-ping Li; Feng Zhu
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.